ABCC1 and epilepsy: Compared with the control group, at 6 weeks after SE, the expression levels of ABCC1 in epilepsy group were not significantly increased (p > .05, Figure 5a and b), but significantly increased in the DRE group (p < .05 Figure 5a and b); at 7 weeks after SE, the levels in epilepsy group were similar to that of the control group (p > .05 Figure 5a and b), but significantly decreased in the DRE group (p < .05 Figure 5a and b); at 9 weeks after SE, the levels in both epilepsy and DRE groups were significantly increased (p < .05 Figure 5a and b).